Ali will participate in the session titled, "Personalizing Cardiovascular Therapies to Address the Underlying Causes of Disease." The panel will discuss cell and gene therapies in cardiovascular medicine. Tenaya Therapeutics will also have a company presentation at 4:45 p.m. PT on October 13.
Tenaya Therapeutics develops gene therapies for rare genetic disorders and for more prevalent heart conditions through three product platforms: gene therapy, cellular regeneration, and precision medicine.
Copyright © 2021 scienceboard.net